RAPT Q1 2022 Earnings — RAPT Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RAPTRAPT Therapeutics, Inc.

$959M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$641,000-47.5% YoY

Gross Profit

$641,000100.0% margin

Operating Income

-$21M-3241.3% margin

Net Income

-$20M-3193.1% margin

EPS (Diluted)

$-5.54

QoQ Revenue Growth

-15.2%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$16M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$188M

Total Liabilities

$20M

Stockholders' Equity

$168M

Cash & Equivalents

$32M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$641,000	$1M	-47.5%
Gross Profit	$641,000	$1M	-47.5%
Operating Income	-$21M	-$17M	-25.5%
Net Income	-$20M	-$17M	-23.9%